Hemab Therapeutics Revenue

Biotechnology Research • Copenhagen, Capital Region of Denmark, Denmark • 51-100 Employees

Hemab Therapeutics revenue & valuation

Annual revenue	$4,000,000
Revenue per employee	$55,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$12,800,000
Total funding	$135,000,000

Key Contacts at Hemab Therapeutics

Benny Sorensen

Chief Executive Officer

Joseph Vogel

Senior Director, Program Leader

Hans H Wandall

Co-Founder

Ruthvik Malladi

Director Medical Affairs

Per Jeppesen

Director Cmc Dp Development

Prafull S. Gandhi

Senior Director

Samira Farboodmanesh

Sr. Director, Regulatory Affairs

Rane Harrison

Director Of Analytical Development, Cmc

Hanssar Chacón Ugalde

Sr. Director, Pharmacovigilance Operations

Mattias Häger

Scientific Director

Company overview

Headquarters	Ole Maaløes Vej 3, Copenhagen, 2200, DK
Website	hemab.com
NAICS	541714
Keywords	Biotech
Founded	2019
Employees	51-100
Socials

Hemab Therapeutics Email Formats

Hemab Therapeutics uses 2 email formats. The most common is {first initial} (e.g., j@hemab.com), used 64.4% of the time.

Format	Example	Percentage
{first initial}	j@hemab.com	64.4%
{first name}	john@hemab.com	35.6%

About Hemab Therapeutics

Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Based in Cambridge, Massachusetts and Copenhagen, Denmark, Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company’s strategic guidance, Hemab 1-2-5, targets the development of 5 clinical assets by 2025 to deliver long-awaited innovation for patients with high unmet need blood clotting disorders like Glanzmann Thrombasthenia, factor VII deficiency, Bernard Soulier Syndrome, Von Willebrand Disease and other serious disorders. Learn more at hemab.com.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Director

Vice President

Senior

Employees by Department

Hemab Therapeutics has 35 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore Hemab Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-03-21	5	$135,000,000

Funding Insights

$135,000,000

Total funding amount

$135,000,000

Most recent funding amount

Number of funding rounds

Hemab Therapeutics Tech Stack

Discover the technologies and tools that power Hemab Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Microsoft 365

Twitter Emoji

Font scripts

Genesis theme

WordPress themes

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

Adobe Fonts

Font scripts

Google Tag Manager

Tag managers

GoDaddy

Hosting

Nginx

Reverse proxies

Frequently asked questions

Hemab Therapeutics is located in Copenhagen, Capital Region of Denmark, DK.

Hemab Therapeutics generates an estimated annual revenue of $4,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Hemab Therapeutics has an estimated valuation of $12,800,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Hemab Therapeutics was founded in 2019, making it 7 years old. The company has established itself as a significant player in its industry over this time.

Hemab Therapeutics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Hemab Therapeutics has raised a total of $135,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.